Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease characterized by
progressive fibrosing interstitial pneumonia. The histological pattern, which displays dense …

Idiopathic pulmonary fibrosis (IPF) is a chronic disease characterized by fibroblast
expansion, and tissue remodeling. It is considered a multifactorial disease but the possible …

Introduction Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial pneumonia marked by
progressive lung fibrosis and a poor prognosis. Recent studies have highlighted the …

Idiopathic pulmonary fibrosis (IPF) is a lethal lung disorder of unknown etiology. The disease
is likely the result of complex interactions between genetic and environmental factors …

Introduction Idiopathic pulmonary fibrosis (IPF) is a chronic, devastating, and progressive
lung disease that is characterized by fibrosis and respiratory failure. IPF holds high morbidity …

Background Idiopathic pulmonary fibrosis (IPF) is increasingly recognized as a chronic,
progressive and fatal lung disease with an unknown etiology. Current studies focus on …

Numerous published papers are investigating the utility of biomarkers in Idiopathic
Pulmonary Fibrosis (IPF) diagnosis, treatment, and outcome prediction. This chapter will …

Idiopathic pulmonary fibrosis (IPF) is a progressive diffuse interstitial lung disease with poor
prognosis of unknown etiology that leading ultimately to death. Predisposing factors are …

Rationale: Idiopathic pulmonary fibrosis (IPF) is a complex lung disease characterized by
scarring of the lung that is believed to result from an atypical response to injury of the …

Abstract Background Genetic variations in Idiopathic Pulmonary Fibrosis (IPF) affect survival
and outcomes. Current antifibrotic agents are managed based on the patient's reported side …